Patents by Inventor Alfred Theodore Harding

Alfred Theodore Harding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENGINEERED INFLUENZA POLYNUCLEOTIDES, VIRUSES, VACCINES AND METHODS OF MAKING AND USING THE SAME
    Publication number: 20230285537
    Abstract: Engineered Influenza polynucleotides, viruses, vaccines, and methods of making and using the same are provided. More specifically, the present inventors have developed replication competent engineered influenza viruses having, for example, a modified segment 4 and/or segment 6 that include at least one additional polynucleotide encoding a heterologous polypeptide.
    Type: Application
    Filed: January 30, 2023
    Publication date: September 14, 2023
    Inventors: Nicholas Scott Heaton, Alfred Theodore Harding, Brook Elizabeth Heaton
  • Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same
    Patent number: 11596683
    Abstract: Engineered Influenza polynucleotides, viruses, vaccines, and methods of making and using the same are provided. More specifically, the present inventors have developed replication competent engineered influenza viruses having, for example, a modified segment 4 and/or segment 6 that include at least one additional polynucleotide encoding a heterologous polypeptide.
    Type: Grant
    Filed: July 12, 2017
    Date of Patent: March 7, 2023
    Assignee: Duke University
    Inventors: Nicholas Scott Heaton, Alfred Theodore Harding, Brook Elizabeth Heaton
  • ENGINEERED INFLUENZA POLYNUCLEOTIDES, VIRUSES, VACCINES AND METHODS OF MAKING AND USING THE SAME
    Publication number: 20190224305
    Abstract: Engineered Influenza polynucleotides, viruses, vaccines, and methods of making and using the same are provided. More specifically, the present inventors have developed replication competent engineered influenza viruses having, for example, a modified segment 4 and/or segment 6 that include at least one additional polynucleotide encoding a heterologous polypeptide.
    Type: Application
    Filed: July 12, 2017
    Publication date: July 25, 2019
    Applicant: Duke University
    Inventors: Nicholas Scott Heaton, Alfred Theodore Harding, Brook Elizabeth Heaton